Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143076 |
| CAS No | NA |
| Mol.F. | C22H23ClN8O |
| Mol.Wt. | 450.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143077 |
| CAS No | NA |
| Mol.F. | C26H30ClN7O2 |
| Mol.Wt. | 508.02 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143078 |
| CAS No | NA |
| Mol.F. | C23H24ClN7O2 |
| Mol.Wt. | 465.94 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143079 |
| CAS No | NA |
| Mol.F. | C22H21ClN10O |
| Mol.Wt. | 476.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143080 |
| CAS No | NA |
| Mol.F. | C22H21ClN6O2 |
| Mol.Wt. | 465.90 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143081 |
| CAS No | NA |
| Mol.F. | C24H23N5O6S |
| Mol.Wt. | 509.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143082 |
| CAS No | NA |
| Mol.F. | C24H21N5O6S |
| Mol.Wt. | 507.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143083 |
| CAS No | NA |
| Mol.F. | C31H29N5O7S |
| Mol.Wt. | 615.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143084 |
| CAS No | NA |
| Mol.F. | C24H25N5O5S |
| Mol.Wt. | 495.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143085 |
| CAS No | NA |
| Mol.F. | C23H21N5O6S |
| Mol.Wt. | 495.51 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143086 |
| CAS No | NA |
| Mol.F. | C14H11N3O6 |
| Mol.Wt. | 317.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143087 |
| CAS No | NA |
| Mol.F. | C9H8N2O5 |
| Mol.Wt. | 224.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143088 |
| CAS No | NA |
| Mol.F. | C11H12N2O5 |
| Mol.Wt. | 252.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143089 |
| CAS No | NA |
| Mol.F. | C8H6N2O5 |
| Mol.Wt. | 210.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143090 |
| CAS No | NA |
| Mol.F. | C10H10N2O5 |
| Mol.Wt. | 238.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143091 |
| CAS No | NA |
| Mol.F. | C13H16N2O9 |
| Mol.Wt. | 344.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |